Researchers in Japan have taken a major step toward eliminating Down syndrome by using advanced gene-editing technology to erase the genetic defect at its source.
The study, published in PNAS Nexus, details how scientists at Mie University used CRISPR-Cas9 to remove the extra chromosome 21 from lab-grown cells.
This surplus chromosome causes Down syndrome, or trisomy 21, a genetic condition that affects around one in every 700 births in the United States. It leads to abnormal gene expression, developmental delays, intellectual disabilities, and multiple health complications.
Precise chromosome removal reshapes gene activity
Led by Ryotaro Hashizume, the research team designed CRISPR guides to target only the extra chromosome—an approach known as allele-specific editing.
Japanese scientists have successfully removed the extra chromosome which causes Down syndrome, from affected cells in a laboratory setting using CRISPR-Cas9 gene editing technology pic.twitter.com/N1oG5gZd5I
— Science girl (@gunsnrosesgirl3) July 25, 2025
Once the surplus chromosome was removed, the corrected cells began to behave more typically. Genes related to nervous system development became more active, while genes tied to metabolism showed reduced activity.
The researchers reported that the edited cells grew faster and divided more rapidly than untreated ones, suggesting a release from the biological stress caused by the extra genetic material.
The technique succeeds in mature human cells
To further test the method’s potential, the team applied the CRISPR system to fibroblasts—mature skin cells taken from individuals with Down syndrome.
In several cases, they successfully removed the additional chromosome even in these fully developed cells. This demonstrates that the technique could work beyond early development, marking a significant step for future therapeutic use.
The editing system still requires refinement
Despite the promising results, the scientists acknowledge challenges ahead. The CRISPR system occasionally affected healthy chromosomes. The team is now working to improve the system’s accuracy, ensuring it only targets the extra copy of chromosome 21.
The study reveals that CRISPR is capable not only of correcting small mutations but also of deleting an entire chromosome, a medical advancement that could pave the way for regenerative treatments aimed at genetic conditions.
Living with Down syndrome involves lifelong challenges
Down syndrome is linked to a broad range of health issues, including heart defects, immune system disorders, digestive problems, thyroid conditions, and an increased risk of leukemia.
Nearly half of those with the condition are born with a congenital heart defect, most often an atrioventricular septal defect. They also face higher rates of hearing loss, vision problems, dental issues, and sleep apnea.
As individuals with Down syndrome age, they are significantly more likely to develop dementia related to Alzheimer’s. Researchers believe this is due to the overproduction of amyloid precursor protein, contributing to the buildup of amyloid plaques in the brain.
Ethical debate surrounds genetic intervention
Efforts to eliminate Down syndrome have sparked global debate. Iceland has faced scrutiny in recent years for dramatically reducing the number of births involving the condition, largely due to widespread use of prenatal testing followed by termination.
Ástríður Stefánsdóttir, a medical doctor and professor of applied ethics at the University of Iceland, explained that many people with Down syndrome, along with their families, find these developments deeply unsettling. She emphasized that it is important to include their voices in ongoing discussions about genetics, ethics, and choice.
See all the latest news from Greece and the world at Greekreporter.com. Contact our newsroom to report an update or send your story, photos and videos. Follow GR on Google News and subscribe here to our daily email!


